Belleville, NJ
1 Clara Maass Drive, Ste. 200
Belleville NJ 07109
Belleville NJ 07109
mon-fri8:00 AM - 4:30 PM
saturdayClosed
sundayClosed
New Patients: For your convenience, please download, print out and complete the New Patient and Patient Medical History Forms and bring to your initial visit.
PATIENT FORMS
- General Consent for RCCA Services
- ACP Screener
- Pharmacy and Prescription Benefit Plan Information Form
- HIPAA acknowledgement
- Consultation Checklist & Radiology Policy
- New Jersey Immunization Information Systems (NJIIS) Consent to Participate
- Autorización de inscripción en el sistema de información sobre vacunación de nueva jersey
- Patient Finanical Assistance
Cancer Treatment Center in
Belleville, NJ
Regional Cancer Care Associates provides the latest in cancer and blood disorder treatments to more than 250,000 patients at community-based clinics throughout New Jersey, Connecticut, Maryland, and the Washington DC area. It is our pleasure to now offer our superior quality of care to the people of Belleville, NJ and nearby communities.
We understand that living with cancer is enough of a challenge without having to travel a considerable distance to receive treatment. We specialize in all aspects of oncology and hematology, ensuring that you receive the cutting-edge therapies and deep expertise you need without undue stress or inconvenience. Find out more about the innovative, evidence-based treatments and comprehensive services we offer. Make an appointment with Regional Cancer Care Associates of Belleville, NJ today.
Contact Us for More Information
Schedule an appointment at our office at 1 Clara Maass Dr, Ste 200 Belleville NJ, 07109. You can get in touch with us through our online form.
Regional Cancer Care Associates of Belleville, NJ provides:
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.